NCT04181437View on ClinicalTrials.gov

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 17, 2020

Study Completion Date

May 29, 2020

Conditions
Healthy
Interventions
DRUG

NVP-1203-R1

1 tablet, Single oral dosing

DRUG

NVP-1203-R2

1 tablet, Single oral dosing

DRUG

NVP-1203-R1 and NVP-1203-R2

NVP-1203-R1,1 tablet and NVP-1203-R2, 1 tablet, co-administration, single oral dosing

Trial Locations (1)

700-721

Kyungpook National University Hospital, Daegu

Sponsors

Lead Sponsor

NVP Healthcare
All Listed Sponsors
lead

NVP Healthcare

INDUSTRY